RE-BVS – Piemonte Repository

Sfoglia per AUTORE
WANG S
Collezione AOU Città della Salute di Torino

Items : 7

Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses. in EBioMedicine / EBioMedicine. 2024 Oct;108:105341. doi: 10.1016/j.ebiom.2024.105341. Epub 2024 Sep 14.

2024
AOU Città della Salute di Torino

Wang SE; Viallon V; Lee M; Dimou N; Hamilton F; Biessy C; O'Mara T; Kyrgiou M; Crosbie EJ; Truong T; Severi G; Kaaks R; Fortner RT; Schulze MB; Bendinelli B; Sabina S; Tumino R; Sacerdote C; Panico S; Crous-Bou M; Sánchez MJ; Aizpurua A; Palacios DR; Guevara M; Travis RC; Tsilidis KK; Heath A; Yarmolinsky J; Rinaldi S; et alii...

30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis. in HemaSphere / Hemasphere. 2024 Nov 5;8(11):e70041. doi: 10.1002/hem3.70041. eCollection 2024 Nov.

2024
AOU Città della Salute di Torino

Ocio EM; Perrot A; Moreau P; Mateos MV; Bringhen S; Martínez-López J; Karlin L; Wang SY; Oprea C; Li Y; Kodas E; San-Miguel J;

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension. in CJC open / CJC Open. 2024 Mar 4;6(6):805-810. doi: 10.1016/j.cjco.2024.02.002. eCollection 2024 Jun.

2024
AOU Città della Salute di Torino

Klein AL; Clair J; Wang S; Wasserstrum Y; Luis SA; Lin D; LeWinter M; Klutstein M; Insalaco A; Arad M; Cremer PC; Trotta L; Brucato A; Imazio M; Paolini JF;

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis. in Clinical journal of the American Society of Nephrology : CJASN / Clin J Am Soc Nephrol. 2024 Apr 1;19(4):438-451. doi: 10.2215/CJN.0000000000000398. Epub 2024 Jan 23

2024
AOU Città della Salute di Torino

Joh K; Hou J; Hernandez LH; Eldin K; Cornea V; Comstock JM; Becker JU; Barreca A; Bajema I; Avila-Casado C; Maixnerova D; Tesar V; Liu ZH; Shi S; Zhang H; Materassi M; Santoro D; Conti G; Fujimoto S; Takafumi I; Yokoo T; Tsuboi N; Pecoraro C; Pohl M; Hackl A; Weber LT; Koskela M; Nuutinen M; Nakatani S; et alii...

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. in Leukemia / Leukemia. 2023 Jul;37(7):1521-1529. doi: 10.1038/s41375-023-01936-7. Epub 2023 Jun 14.

2023
AOU Città della Salute di Torino

Ocio EM; Perrot A; Bories P; San-Miguel JF; Blau IW; Karlin L; Martinez-Lopez J; Wang SY; Bringhen S; Marcatti M; Mateos MV; Rodriguez-Otero P; Oliva S; Nogai A; Le Roux N; Dong L; Macé S; Gassiot M; Fitzmaurice T; Oprea C; Moreau P;

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.

2018
AOU Città della Salute di Torino

Salles G; Cheson BD; Vermeulen J; Balasubramanian S; Schaffer M; Damle RN; Wang SS; Gartenberg GJ; Deshpande S; Caballero D; Morton J; Jurczak W; Radford J; Spencer A; Vitolo U; Martin P; Lill M; Yacoub A; Hou JZ; Hess G; Trotman J; Fowler NH; Schuster SJ; Gopal AK; Gopal AK; Schuster SJ; Fowler NH; Trotman J; Hess G; et alii...

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. in Science translational medicine / Sci Transl Med. 2016 Jun 1;8(341):341ra76. doi: 10.1126/scitranslmed.aad3744.

2016
AOU Città della Salute di Torino

Scott RA; Freitag DF; Li L; Chu AY; Surendran P; Young R; Grarup N; Stancáková A; Chen Y; Varga TV; Yaghootkar H; Luan J; Zhao JH; Willems SM; Wessel J; Wang S; Maruthur N; Michailidou K; Pirie A; van der Lee SJ; Gillson C; Al Olama AA; Amouyel P; Arriola L; Arveiler D; Aviles-Olmos I; Balkau B; Barricarte A; Barroso I; et alii...